Guideline | Drug Name |
---|---|
Retevmo (selpercatinib) | Retevmo (selpercatinib) |
Revcovi (elapegademase-IvIr) | Revcovi (elapegademase-IvIr) |
Revlimid (lenalidomide) | Revlimid (lenalidomide) |
Riluzole Products - PA, NF | Exservan (riluzole film), Rilutek (riluzole tablets), Tiglutik (riluzole suspension), Teglutik (riluzole suspension) |
Rinvoq (upadacitinib) | Rinvoq (upadacitinib) ER tablets, Rinvoq LQ (upadacitinib) oral solution, Rinvoq (upadacitinib) extended-release (ER) tablets |
Rituxan Hycela (rituximab and hyaluronidase human) | Rituxan Hycela (rituximab and hyaluronidase human) |
Rituximab - PA, NF | Riabni (rituximab-arrx), Rituxan (rituximab), Ruxience (rituximab-pvvr), Truxima (rituximab-abbs) |
Roszet (rosuvastatin/ezetimibe) - NF | Roszet (rosuvastatin/ezetimibe) |
Rozlytrek (entrectinib) | Rozlytrek (entrectinib) |
Rubraca (rucaparib) | Rubraca (rucaparib) |
Rydapt (midostaurin) | Rydapt (midostaurin) capsules |
Sabril, Vigadrone, Vigafyde, Vigpoder (vigabatrin) | Sabril (vigabatrin), Vigadrone (vigabatrin), Vigpoder (vigabatrin), Vigafyde (vigabatrin) |
Sapropterin Products | Javygtor (sapropterin dihydrochloride), Kuvan (sapropterin dihydrochloride) |
Savella (milnacipran) | Savella (milnacipran) |
Selzentry (maraviroc) | Selzentry (maraviroc) |
Sensipar (cinacalcet) | Sensipar (cinacalcet) |
SGLT2 Inhibitors - ST, NF | Brenzavvy (bexagliflozin), Inpefa, Invokamet (canagliflozin/metformin), Invokamet XR (canagliflozin/metformin), Invokana (canagliflozin), Qtern (dapagliflozin and saxagliptin), Segluromet (ertugliflozin and metformin), Steglatro (ertugliflozin), Steglujan (ertugliflozin and sitagliptin) |
Signifor, Signifor LAR (pasireotide) - PA, NF | Signifor (pasireotide), Signifor LAR (pasireotide) |
Siliq (brodalumab) - PA, NF | Siliq (brodalumab) |
Simponi, Simponi Aria (golimumab) | Simponi (golimumab) - for subcutaneous use, Simponi Aria (golimumab) - for intravenous use |